Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 9 studies | 26% ± 8% | |
type I pneumocyte | 5 studies | 20% ± 4% | |
type II pneumocyte | 5 studies | 23% ± 4% | |
endothelial cell of lymphatic vessel | 4 studies | 28% ± 9% | |
type B pancreatic cell | 3 studies | 38% ± 11% | |
epithelial cell | 3 studies | 17% ± 2% | |
hepatocyte | 3 studies | 50% ± 16% | |
astrocyte | 3 studies | 26% ± 9% | |
macrophage | 3 studies | 31% ± 13% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
pancreas | 3 studies | 24% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
kidney | 100% | 1398.43 | 89 / 89 | 98% | 9.42 | 882 / 901 |
pancreas | 100% | 2772.17 | 328 / 328 | 97% | 12.43 | 173 / 178 |
stomach | 99% | 749.14 | 356 / 359 | 98% | 7.06 | 279 / 286 |
prostate | 98% | 640.25 | 240 / 245 | 98% | 6.67 | 494 / 502 |
thymus | 100% | 1511.32 | 653 / 653 | 96% | 16.45 | 578 / 605 |
intestine | 96% | 570.38 | 930 / 966 | 99% | 8.25 | 520 / 527 |
liver | 100% | 1329.43 | 226 / 226 | 93% | 5.59 | 376 / 406 |
adrenal gland | 100% | 1898.06 | 258 / 258 | 90% | 17.73 | 208 / 230 |
bladder | 100% | 569.52 | 21 / 21 | 87% | 7.31 | 436 / 504 |
lung | 99% | 1141.26 | 575 / 578 | 85% | 9.10 | 983 / 1155 |
breast | 100% | 1065.78 | 459 / 459 | 82% | 6.34 | 918 / 1118 |
esophagus | 98% | 531.30 | 1417 / 1445 | 70% | 5.20 | 129 / 183 |
ovary | 100% | 964.18 | 180 / 180 | 59% | 3.69 | 255 / 430 |
uterus | 97% | 363.67 | 165 / 170 | 61% | 3.25 | 279 / 459 |
brain | 67% | 241.78 | 1775 / 2642 | 65% | 1.95 | 456 / 705 |
adipose | 100% | 1015.67 | 1204 / 1204 | 0% | 0 | 0 / 0 |
spleen | 100% | 1891.02 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 5.76 | 1 / 1 |
heart | 93% | 361.06 | 805 / 861 | 0% | 0 | 0 / 0 |
muscle | 93% | 516.66 | 747 / 803 | 0% | 0 | 0 / 0 |
skin | 75% | 337.04 | 1354 / 1809 | 12% | 0.47 | 57 / 472 |
tonsil | 0% | 0 | 0 / 0 | 64% | 3.54 | 29 / 45 |
blood vessel | 55% | 184.93 | 736 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 51% | 2.02 | 41 / 80 |
lymph node | 0% | 0 | 0 / 0 | 31% | 0.95 | 9 / 29 |
peripheral blood | 31% | 78.52 | 285 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0017158 | Biological process | regulation of calcium ion-dependent exocytosis |
GO_0007186 | Biological process | G protein-coupled receptor signaling pathway |
GO_0006886 | Biological process | intracellular protein transport |
GO_0006887 | Biological process | exocytosis |
GO_0061669 | Biological process | spontaneous neurotransmitter secretion |
GO_0045744 | Biological process | negative regulation of G protein-coupled receptor signaling pathway |
GO_0032024 | Biological process | positive regulation of insulin secretion |
GO_0042593 | Biological process | glucose homeostasis |
GO_0098793 | Cellular component | presynapse |
GO_0030658 | Cellular component | transport vesicle membrane |
GO_0045202 | Cellular component | synapse |
GO_0005737 | Cellular component | cytoplasm |
GO_0008092 | Molecular function | cytoskeletal protein binding |
GO_0005515 | Molecular function | protein binding |
GO_0031267 | Molecular function | small GTPase binding |
GO_0046872 | Molecular function | metal ion binding |
Gene name | RPH3AL |
Protein name | Rab effector Noc2 (No C2 domains protein) (Rabphilin-3A-like protein) Rab effector Noc2 (Rabphilin 3A like (without C2 domains)) Rab effector Noc2 |
Synonyms | NOC2 |
Description | FUNCTION: Rab GTPase effector involved in the late steps of regulated exocytosis, both in endocrine and exocrine cells (By similarity). Acts as a potential RAB3B effector protein in epithelial cells. . |
Accessions | ENST00000632576.1 ENST00000608519.5 [Q9UNE2-2] ENST00000632071.1 I3L2G8 ENST00000573780.5 ENST00000633904.1 ENST00000574953.5 I3L2W0 I3L2I9 ENST00000632545.1 [Q9UNE2-2] ENST00000633184.1 I3NI49 ENST00000574722.5 ENST00000632000.1 [Q9UNE2-2] ENST00000633046.1 ENST00000632337.1 A0A0J9YWA6 ENST00000570638.5 ENST00000323434.12 [Q9UNE2-2] I3L2X0 I3L181 ENST00000631901.1 ENST00000575130.5 ENST00000608278.2 [Q9UNE2-1] ENST00000632511.1 ENST00000633726.1 Q9UNE2 ENST00000633301.1 ENST00000331302.12 [Q9UNE2-1] ENST00000576420.5 ENST00000633744.1 I3L2N0 I3L349 ENST00000575736.5 I3L1Q0 ENST00000632671.1 ENST00000575634.5 ENST00000634169.1 ENST00000634024.1 ENST00000618002.4 [Q9UNE2-1] ENST00000632610.1 I3L308 ENST00000633332.1 ENST00000632678.1 ENST00000632083.1 ENST00000632735.1 ENST00000536489.6 [Q9UNE2-2] ENST00000577079.5 I3L3M9 ENST00000634137.1 ENST00000632176.1 ENST00000634042.1 ENST00000573448.1 ENST00000573588.5 ENST00000609977.5 A0A0J9YX72 ENST00000632616.1 [Q9UNE2-1] ENST00000633168.1 |